Zobrazeno 1 - 10
of 231
pro vyhledávání: '"F, Makovec"'
Autor:
C, Webber, C A, Stokes, S, Persiani, F, Makovec, A, McBurney, R P, Kapil, B A, John, M, D'Amato, L F, Chasseaud
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics. 29:15-23
Single oral doses of 14C-dexloxiglumide were rapidly and extensively absorbed in dogs and also eliminated rapidly with a short half-life. Following single intravenous doses, dexloxiglumide was characterised as a drug having a high clearance (30.7 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfd6ea2ba4788240341bfa8fb0d2de1d
https://doi.org/10.1007/bf03190569
https://doi.org/10.1007/bf03190569
Autor:
A. L. Piepoli, D. Lorusso, M.A. Maselli, Vito Guerra, F. Makovec, L. Mennuni, F. Pezzolla, M. L. Caruso
Publikováno v:
Digestive Diseases and Sciences. 46:2773-2778
Cholecystokinin is the most important stimulant of postprandial gallbladder contraction, and a regulator of gallbladder fasting tone. The aim of this study was to evaluate the effect of dexloxiglumide on isolated human gallbladder contraction induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc277277c074faec1415743f969f489c
https://doi.org/10.1023/a:1012748017709
https://doi.org/10.1023/a:1012748017709
Autor:
Alessia Ciogli, Francesco Gasparrini, L. Mennuni, Antonio Varnavas, F. Makovec, Valentina Valenta, Lucia Lassiani
Publikováno v:
Medicinal chemistry (Shariqah (United Arab Emirates)). 1(5)
Starting from our lead compound, VL-0395, an anthranilic acid based CCK1 receptor antagonist, and following the well established "step by step" lead investigation strategy, we describe the final step of the anthranilic acid N-terminal optimization. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9305375287b872796c17e56c36cfa6b4
https://pubmed.ncbi.nlm.nih.gov/16787335
https://pubmed.ncbi.nlm.nih.gov/16787335
Autor:
M A, Maselli, A L, Piepoli, F, Pezzolla, V, Guerra, M L, Caruso, L, Mennuni, D, Lorusso, F, Makovec
Publikováno v:
Digestive diseases and sciences. 46(12)
Cholecystokinin is the most important stimulant of postprandial gallbladder contraction, and a regulator of gallbladder fasting tone. The aim of this study was to evaluate the effect of dexloxiglumide on isolated human gallbladder contraction induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fffeb5fbeba472b7f8a47f3b231f7972
https://pubmed.ncbi.nlm.nih.gov/11768273
https://pubmed.ncbi.nlm.nih.gov/11768273
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 21(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a96d0a03f8fdcef4dc24f65eea8663df
https://pubmed.ncbi.nlm.nih.gov/10420394
https://pubmed.ncbi.nlm.nih.gov/10420394
Publikováno v:
Parkinsonism & Related Disorders. 13:S135-S136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1332efd2c14fff33a2c9fbbcaaad6630
https://doi.org/10.1016/s1353-8020(08)70751-x
https://doi.org/10.1016/s1353-8020(08)70751-x
Publikováno v:
Behavioural pharmacology. 9(3)
The effects of CR 2945, an antranilic acid derivative member of a novel family of non-peptide CCKB receptor antagonists, have been compared with those of CAM-1028, an analogue of the CCKB receptor antagonist CI-988, L-365,260 a benzodiazepine derivat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::eabf70f9edbb6830bdc410c7e6ff538b
https://pubmed.ncbi.nlm.nih.gov/9832933
https://pubmed.ncbi.nlm.nih.gov/9832933
Publikováno v:
Asthma Treatment ISBN: 9781461365259
CR 2039 (DIZOLAST) i.e. Benzamide, 4-(1H-tetrazol-5-yl)-N-(4-(1H-tetrazol-5-yl)-phenyl, is a member of a recently discovered new class of potent “allergic mediator release” inhibitors, proposed for the prevention and treatment of asthma and other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb4e6fe0c9877920c89a14df4998b29f
https://doi.org/10.1007/978-1-4615-3446-4_25
https://doi.org/10.1007/978-1-4615-3446-4_25
Autor:
F. Makovec, L. Revel
Publikováno v:
Drugs of the Future. 23:0751
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::085b36bdc1404f91017efc2da1cfada3
https://doi.org/10.1358/dof.1998.023.07.858363
https://doi.org/10.1358/dof.1998.023.07.858363
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.